Targeting peptide iRGD-conjugated amphiphilic chitosan-co-PLA/DPPE drug delivery system for enhanced tumor therapy
- 3 March 2014
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 2 (21) , 3232-3242
Abstract
In this paper, we report a novel targeting drug delivery system, obtained using an amphiphilic chitosan-co-(D,L-lactide)/1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine copolymer (CS-co-PLA/DPPE) with the modification of an iRGD (CRGDKGPDC) peptide as the targeting module. Hydrophilic doxorubicin (DOX) was encapsulated and cell experiments were carried out to evaluate the anti-tumor efficacy of DOX-loaded nanoparticles (NPs) in vitro. Characterization data showed a favorable size distribution, high encapsulation efficiency and a pH-dependent release profile for the synthesized NPs. A cytotoxicity assay revealed the higher inhibitory effect of DOX–iRGD–NPs especially in cell lines with an abundant expression of αvβ3 integrin receptors. An increased cellular uptake of DOX–iRGD–NPs was observed and further confirmed to be a consequence of a specific endocytosis pathway mediated by ligand–receptor interactions. Visualization of the intracellular trafficking showed different distributions of DOX when delivered using DOX–NPs and DOX–iRGD–NPs, proving the targeting effect of iRGD. With the help of the iRGD targeting peptide, a chemotherapeutic drug can be delivered specifically to the cancer and endothelial cells expressing αvβ3 integrin receptors to achieve an enhanced anti-tumor efficacy and controlled drug release.Keywords
This publication has 40 references indexed in Scilit:
- Adjuvant Chemotherapy in Older Women with Early-Stage Breast CancerNew England Journal of Medicine, 2009
- Active targeting schemes for nanoparticle systems in cancer therapeuticsAdvanced Drug Delivery Reviews, 2008
- Nanoparticle Imaging of Integrins on Tumor CellsNeoplasia, 2006
- Cell-specific targeting of nanoparticles by multivalent attachment of small moleculesNature Biotechnology, 2005
- Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trialsThe Lancet, 2002
- Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse ModelScience, 1998
- αv Integrins as receptors for tumor targeting by circulating ligandsNature Biotechnology, 1997
- Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients.Journal of Clinical Oncology, 1997
- New Perspectives in Cell Adhesion: RGD and IntegrinsScience, 1987
- Cis-diamminedichloroplatinum (II)Annals of Internal Medicine, 1977